Vestor Capital LLC Sells 421 Shares of The Procter & Gamble Company (NYSE:PG)

Vestor Capital LLC decreased its stake in The Procter & Gamble Company (NYSE:PG) by 0.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 50,122 shares of the company’s stock after selling 421 shares during the period. Vestor Capital LLC’s holdings in Procter & Gamble were worth $8,681,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Cortland Associates Inc. MO lifted its holdings in Procter & Gamble by 1.9% during the third quarter. Cortland Associates Inc. MO now owns 6,770 shares of the company’s stock valued at $1,173,000 after purchasing an additional 129 shares during the last quarter. Ground Swell Capital LLC bought a new stake in shares of Procter & Gamble in the third quarter valued at approximately $395,000. Robeco Institutional Asset Management B.V. boosted its holdings in Procter & Gamble by 0.7% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 2,847,204 shares of the company’s stock worth $493,136,000 after buying an additional 19,096 shares during the period. Blue Square Asset Management LLC boosted its holdings in Procter & Gamble by 1.2% in the 3rd quarter. Blue Square Asset Management LLC now owns 11,112 shares of the company’s stock worth $1,925,000 after buying an additional 135 shares during the period. Finally, BSW Wealth Partners grew its stake in Procter & Gamble by 0.9% in the 3rd quarter. BSW Wealth Partners now owns 28,136 shares of the company’s stock valued at $4,873,000 after buying an additional 264 shares in the last quarter. 65.77% of the stock is owned by institutional investors.

Insider Transactions at Procter & Gamble

In related news, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the sale, the chief executive officer now directly owns 263,537 shares in the company, valued at $44,508,763.93. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the transaction, the chief executive officer now owns 263,537 shares of the company’s stock, valued at $44,508,763.93. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 385,771 shares of company stock worth $65,610,975. Insiders own 0.18% of the company’s stock.

Procter & Gamble Price Performance

PG stock opened at $165.00 on Monday. The firm has a market cap of $388.58 billion, a P/E ratio of 28.47, a P/E/G ratio of 3.57 and a beta of 0.42. The firm’s fifty day moving average is $171.62 and its 200 day moving average is $168.07. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period last year, the firm earned $1.83 earnings per share. The company’s revenue for the quarter was down .6% compared to the same quarter last year. Research analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.44%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Analyst Upgrades and Downgrades

PG has been the subject of a number of analyst reports. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Deutsche Bank Aktiengesellschaft upped their price target on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Stifel Nicolaus raised their price objective on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research report on Monday, July 22nd. Finally, Piper Sandler assumed coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Nine investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.